A new study may have found a specific patient population that may live longer by taking this drug: Colon cancer patients.

After reviewing data from 964 colorectal cancer patients, researchers at the Dana-Farber Cancer Institute in Boston found when patients whose tumors had a mutated form of the PIK3CA gene took aspirin after being diagnosed, they lived significantly longer than patients without the mutation.

(READ the article from CNN)